Industry

Biotechnology

Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.

Total Companies
1 358
Biotechnology Industry
Company Intrinsic Valuation Profitability Score Solvency Score Market Cap
C
Can Fite Biopharma Ltd
TASE:CANF
Loading...
N/A
12 / 100
75 / 100
$49.3T
Abbvie Inc
NYSE:ABBV
Loading...
4% Overvalued
72 / 100
43 / 100
$386.7B
Amgen Inc
NASDAQ:AMGN
Loading...
9% Overvalued
64 / 100
28 / 100
$174B
Gilead Sciences Inc
NASDAQ:GILD
Loading...
3% Overvalued
66 / 100
63 / 100
$153.2B
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Loading...
27% Overvalued
60 / 100
87 / 100
$117.2B
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Loading...
Fairly Valued
58 / 100
97 / 100
$79.5B
CSL Ltd
ASX:CSL
Loading...
22% Undervalued
56 / 100
63 / 100
$56.3B
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Loading...
19% Overvalued
50 / 100
48 / 100
$49.5B
argenx SE
XBRU:ARGX
Loading...
21% Overvalued
56 / 100
99 / 100
$49.3B
Beigene Ltd
SSE:688235
Loading...
28% Overvalued
38 / 100
75 / 100
$39.8B
Beigene Ltd
HKEX:6160
Loading...
20% Overvalued
38 / 100
75 / 100
$37.4B
Insmed Inc
NASDAQ:INSM
Loading...
61% Overvalued
31 / 100
61 / 100
$35.2B
Celltrion Inc
KRX:068270
Loading...
29% Overvalued
49 / 100
69 / 100
$32.8B
Natera Inc
NASDAQ:NTRA
Loading...
58% Overvalued
29 / 100
71 / 100
$32.2B
Biogen Inc
NASDAQ:BIIB
Loading...
7% Undervalued
53 / 100
64 / 100
$26.9B
BioNTech SE
NASDAQ:BNTX
Loading...
45% Overvalued
39 / 100
75 / 100
$25.5B
Revolution Medicines Inc
NASDAQ:RVMD
Loading...
N/A
21 / 100
85 / 100
$22.2B
Incyte Corp
NASDAQ:INCY
Loading...
3% Overvalued
66 / 100
85 / 100
$20.8B
Genmab A/S
CSE:GMAB
Loading...
79% Overvalued
70 / 100
99 / 100
$20.6B
United Therapeutics Corp
NASDAQ:UTHR
Loading...
19% Overvalued
70 / 100
93 / 100
$20.5B
Load More